News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
September, 2024
September 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Yüksel Ürün: Proud to be part of the esteemed KCRS24 Abstract Committee
Photo taken from Yüksel Ürün/X
Jul 12, 2024, 14:26

Yüksel Ürün: Proud to be part of the esteemed KCRS24 Abstract Committee

Yüksel Ürün, Medical Oncologist at Ankara University, shared on X:

“Proud to be part of the esteemed KCRS24 Abstract Committee with these incredible colleagues! Honored to contribute to advancing kidney cancer research.”

Source: Yüksel Ürün/X

Abstract Committee Ankara University cancer KCRS24 kidney cancer research OncoDaily Oncology Yüksel Ürün
Special Coverage
Insight
Sep 15, 2024, 13:20
Myeloma Paper of the Day, September 15th, suggested by Robert Orlowski
Blog
Sep 15, 2024, 12:53
Sumanta Pal's highlights from ESMO24
Insight
Sep 15, 2024, 12:48
Shahrin Ahmed: The phase III trial was successful in the performance of the radiotracer for kidney cancer
Insight
Sep 15, 2024, 12:42
Zainab Shinkafi-Bagudu: The voices of traditional rulers are the bridge between science and the people that need life saving information
Blog
Sep 15, 2024, 12:37
The representation of female oncologists in leadership roles - ESMO
Societies
Sep 15, 2024, 10:47
No role for pre-operative CRT in the treatment of operable Gastric cancer - ESMO
Blog
Sep 15, 2024, 10:40
Jerome Foucaud: Pleased to contribute to the ESMO session - 'the assessment of citizens perception of risk'
Blog
Sep 15, 2024, 10:22
Elvina Almuradova: DisACcontinuing anti-HER2 treatment in super responders could be considered
Career
Sep 15, 2024, 10:16
Alan Ho Appointed as Chief of the Head and Neck Oncology Service at MSK
Insight
Sep 15, 2024, 10:09
Mark Lawler: Honoured to be on the Health Research Board
Career
Sep 15, 2024, 10:02
Welcome Diego de Miguel Perez to Ohio State Medical Oncology! 
Blog
Sep 15, 2024, 09:55
Rasha Aboelhassan: Should we try immunotherapy for all patients?